Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) has one of the poorest prognosis among malignancies. Thus, the identification of markers useful in developing innovative diagnostic and therapeutic methods is an imperative need. Folate receptor alpha (FRα) has been associated with prognosis in several cancers...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Lei, Michelakos, Theodoros, Ferrone, Cristina R., Zhang, Liyuan, Deshpande, Vikram, Shen, Qi, DeLeo, Albert, Yamada, Teppei, Zhang, Gong, Ferrone, Soldano, Wang, Xinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514937/
https://www.ncbi.nlm.nih.gov/pubmed/28430580
http://dx.doi.org/10.18632/oncotarget.16841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514937/
https://www.ncbi.nlm.nih.gov/pubmed/28430580
http://dx.doi.org/10.18632/oncotarget.16841

Ejemplares similares